The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics, prognosis and treatments of 294 patients with poorly differentiated neuroendocrine carcinoma: The FFCD-GTE national cohort.
 
Thomas Walter
Consulting or Advisory Role - Celgene; Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Novartis
 
David Tougeron
No Relationships to Disclose
 
Eric Baudin
No Relationships to Disclose
 
Karine Le Malicot
No Relationships to Disclose
 
Thierry Lecomte
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Celgene; Ipsen; Novartis
 
Joel Guigay
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MERCK SERONO (Inst)
 
Olivia Hentic
No Relationships to Disclose
 
Sylvain Manfredi
No Relationships to Disclose
 
Isabelle Bonnet
No Relationships to Disclose
 
Rosine Guimbaud
No Relationships to Disclose
 
Romain Coriat
Consulting or Advisory Role - Merck; Novartis; Pfizer
 
Philippe Rougier
No Relationships to Disclose
 
Christophe Desauw
No Relationships to Disclose
 
Anne Thirot-Bidault
Consulting or Advisory Role - Sanofi
 
Laetitia Dahan
No Relationships to Disclose
 
Guillaume Roquin
No Relationships to Disclose
 
Thomas Aparicio
No Relationships to Disclose
 
Catherine Lombard-Bohas
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Ipsen; Novartis
 
Come Lepage
No Relationships to Disclose
 
Guillaume Cadiot
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Research Funding - Ipsen
Travel, Accommodations, Expenses - Ferring; Ipsen; Novartis; Pfizer